Mostrar el registro sencillo

dc.contributor.authorSlot, Margot I. E.es_ES
dc.contributor.authorUrquijo Castro, Maria F.es_ES
dc.contributor.authorWinter Van Rossum, Ingees_ES
dc.contributor.authorVan Hell, Hendrika H.es_ES
dc.contributor.authorDwyer, Dominices_ES
dc.contributor.authorDazzan, Paolaes_ES
dc.contributor.authorMaat, Arijaes_ES
dc.contributor.authorDe Haan, Lieuwees_ES
dc.contributor.authorCrespo Facorro, Benedicto es_ES
dc.contributor.authorGlenthøj, Birtees_ES
dc.contributor.authorLawrie, Stephen M.es_ES
dc.contributor.authorMcDonald, Colmes_ES
dc.contributor.authorGruber, Oliveres_ES
dc.contributor.authorVan Amelsvoort, Thérèsees_ES
dc.contributor.authorArango, Celsoes_ES
dc.contributor.authorKircher, Tiloes_ES
dc.contributor.authorTordesillas Gutiérrez, Diana es_ES
dc.contributor.authorSetién Suero, María Estheres_ES
dc.contributor.authorAyesa Arriola, Rosa es_ES
dc.contributor.authorSuárez Pinilla, Paula es_ES
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2025-01-31T12:59:22Z
dc.date.available2025-01-31T12:59:22Z
dc.date.issued2024es_ES
dc.identifier.issn2754-6993es_ES
dc.identifier.urihttps://hdl.handle.net/10902/35293
dc.description.abstractSeveral multivariate prognostic models have been published to predict outcomes in patients with first episode psychosis (FEP), but it remains unclear whether those predictions generalize to independent populations. Using a subset of demographic and clinical baseline predictors, we aimed to develop and externally validate different models predicting functional outcome after a FEP in the context of a schizophrenia-spectrum disorder (FES), based on a previously published cross-validation and machine learning pipeline. A crossover validation approach was adopted in two large, international cohorts (EUFEST, n = 338, and the PSYSCAN FES cohort, n = 226). Scores on the Global Assessment of Functioning scale (GAF) at 12 month follow-up were dichotomized to differentiate between poor (GAF current < 65) and good outcome (GAF current ≥ 65). Pooled non-linear support vector machine (SVM) classifiers trained on the separate cohorts identified patients with a poor outcome with cross-validated balanced accuracies (BAC) of 65-66%, but BAC dropped substantially when the models were applied to patients from a different FES cohort (BAC = 50–56%). A leave-site-out analysis on the merged sample yielded better performance (BAC = 72%), highlighting the effect of combining data from different study designs to overcome calibration issues and improve model transportability. In conclusion, our results indicate that validation of prediction models in an independent sample is essential in assessing the true value of the model. Future external validation studies, as well as attempts to harmonize data collection across studies, are recommended.es_ES
dc.description.sponsorshipWe acknowledge the contributions of the entire EUFEST and PSYSCAN consortia. EUFEST was funded by the European Group for Research in Schizophrenia (EGRIS) with grants from AstraZeneca, Pfizer and Sanofi Aventis. PSYSCAN was funded as part of the European Funding 7th Framework Programme (grant agreement no 603196)
dc.format.extent11 p.es_ES
dc.language.isoenges_ES
dc.rights© The Author(s) 2024. This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceSchizophrenia, 2024, 10(1), 89es_ES
dc.titleMultivariable prediction of functional outcome after first-episode psychosis: a crossover validation approach in EUFEST and PSYSCAN.es_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.1038/s41537-024-00505-wes_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.1038/s41537-024-00505-wes_ES
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

© The Author(s) 2024. This article is licensed under a Creative Commons
Attribution-NonCommercial-NoDerivatives 4.0 International License,
which permits any non-commercial use, sharing, distribution and reproduction in any
medium or format, as long as you give appropriate credit to the original author(s) and
the source, provide a link to the Creative Commons licence, and indicate if you modified
the licensed material. You do not have permission under this licence to share adapted
material derived from this article or parts of it. The images or other third party material in
this article are included in the article’s Creative Commons licence, unless indicated
otherwise in a credit line to the material. If material is not included in the article’s
Creative Commons licence and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly
from the copyright holder. To view a copy of this licence, visit http://
creativecommons.org/licenses/by-nc-nd/4.0/Excepto si se señala otra cosa, la licencia del ítem se describe como © The Author(s) 2024. This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/